Practice Tip: Keshav Bhat, OD, MS, recommends offering “sample” contact lenses to patients who have myopia. Specifically, by having a complete fitting set of lenses designed specifically for myopia management on hand, he can place a pair of diagnostic lenses in the child’s eye during the initial consultation. “I find that this practice usually confirms the ease of the [fitting] process and convinces parents to have the child take home a few to practice the insertion/removal procedures. This experience often translates to buy-in,” he writes in “Persuade Parents to Support Myopia Management,” at https://www.optometricmanagement.com/issues/2022/september-2022/persuade-parents-to-support-myopia-management.  
 
Bausch + Lomb and Novaliq Get FDA Nod for New Drug Application 
for Dry Eye Disease Drug
Bausch + Lomb and Novaliq GmbH announced that the FDA accepted the New Drug Application filing for NOV03 (perfluorohexyloctane), an investigational treatment for the signs and symptoms of dry eye disease associated with meibomian gland dysfunction. NOV03 has been assigned a Prescription Drug User Fee Act (PDUFA) action date of June 28, 2023.

Build My Team Announces Launch of Outsourced Hiring Service
Build My Team launched its outsourced hiring service for eye care practices. Specifically, the service is a hiring alternative for eye care practices that struggle to find high-quality job candidates for their open positions. Additionally, it comes with the guarantee that it will provide additional candidates for an open position until it has been filled at no extra charge, if, for any reason, a hiree recommended from Build My Team leaves within three months. For more information, visit www.buildmyteam.com.

CooperVision MiSight and EssilorLuxottica Launch 
Myopia Control Contact Lenses in China
CooperVision and EssilorLuxottica launched MiSight 1 day contact lenses in China, where the Chinese National Medical Products Administration gave the lenses the thumbs up for slowing the progression of axial length. EssilorLuxottica is the exclusive distributor of MiSight 1 day in China’s mainland. During a livestreamed event, CooperVision discussed the science behind MiSight 1 day contact lenses, the role of measuring axial length, and healthy wear in children. 

Centre for Ocular Research & Education’s Contact Lens Update Focuses on Myopia
The Centre for Ocular Research & Education (CORE)’s Issue 67 of Contact Lens Update focuses on the most recent evidence and best practices in myopia management, according to a CORE press release. The issue features commentary from Mark Bullimore, scientist and adjunct professor at the University of Houston; Paul Chamberlain, senior director of Research Programs at CooperVision; Noel Brennan, research fellow at Johnson & Johnson Vision; Debbie Jones, clinical professor at the School of Optometry & Vision Science, University of Waterloo; and more. The new edition and all past issues are available for free at ContactLensUpdate.com.

Vyluma Finishes Final Patient Visit for Myopia Treatment Study
Vyluma, Inc., a biopharmaceutical company developing assets for the treatment of refractive errors, announced that the last patient visit has been completed for the primary analysis of its Phase 3 Childhood Atropine for Myopia Progression (CHAMP) clinical study. The study is designed to assess whether NVK002 eye drops are a safe and effective treatment for myopia progression in children. NVK002 is a proprietary, investigational, preservative-free eye drop administered nightly. CHAMP consists of a three-year study period to evaluate the safety and efficacy of NVK002, followed by a re-randomized, masked, one-year study period to characterize cessation of therapy.

OD Notebook is published weekly on Wednesdays. Unless otherwise noted, the information presented is based on press releases and/or announcements by the respective organizations. Find earlier editions here. To submit a press release to be considered for publication, click here.